Search results for "nutraceutical."

showing 10 items of 177 documents

Fruit and Vegetable Derived Waste as a Sustainable Alternative Source of Nutraceutical Compounds

2018

Dietary phytochemicals are widely investigated in the eld of chemistry, biology, nutrition, and medicine for their potential health-promoting e‚ects. Indeed, many in vitro and in vivo studies provide evidence that a number of these compounds are involved in the prevention and/or control of chronic disorders such as cancer and cardiovascular diseases. e exponential growth of plant waste production from the agrofood industry is a critical global issue, considering its storage, disposal, environmental impact, and potential health risks. However, the exploitation of plant wastes/by-products for the recovery of added-value compounds o‚ers new avenue for industrial growth and waste management. I…

Article Subjectlcsh:TX341-64102 engineering and technology010501 environmental sciences021001 nanoscience & nanotechnology01 natural sciencesNutraceuticalSettore BIO/10 - BiochimicaEnvironmental scienceFood science0210 nano-technologySafety Risk Reliability and Qualitylcsh:Nutrition. Foods and food supply0105 earth and related environmental sciencesFood ScienceJournal of Food Quality
researchProduct

GSK-3? Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutra…

2021

Glycogen synthase kinase-3 (GSK-3) is a regulator of signaling pathways. KRas is frequently mutated in pancreatic cancers. The growth of certain pancreatic cancers is KRas-dependent and can be suppressed by GSK-3 inhibitors, documenting a link between KRas and GSK-3. To further elucidate the roles of GSK-3β in drug-resistance, we transfected KRas-dependent MIA-PaCa-2 pancreatic cells with wild-type (WT) and kinase-dead (KD) forms of GSK-3β. Transfection of MIA-PaCa-2 cells with WT-GSK-3β increased their resistance to various chemotherapeutic drugs and certain small molecule inhibitors. Transfection of cells with KD-GSK-3β often increased therapeutic sensitivity. An exception was observed wi…

Berberineendocrine system diseasesmedicine.medical_treatmentRegulatormedicine.disease_causeDeoxycytidinePiperazinesTargeted therapychemotherapeutic drugsTargeted therapyNitrophenolsBreast cancerGSK-3BGlycolysisMolecular Targeted TherapyNeoplasm Metastasistargeted therapy;lcsh:QH301-705.5Tumor Stem Cell AssaySulfonamidesTumorbiologyChemistryGeneral MedicineTransfectionMetforminDisease ProgressionMCF-7 CellsFemaleKRASNutraceuticalsFluorouracilSignal transductionGlycolysisSignal TransductionBCL2bcl-X ProteinAntineoplastic AgentsBreast Neoplasmsmacromolecular substancesAdenocarcinomaArticleCell LineInhibitory Concentration 50Cell Line TumorThiadiazolesmedicineDiabetes MellitusKRasHumansGlycogen synthaseProtein Kinase InhibitorsCell ProliferationChemotherapeu-tic drugsGlycogen Synthase Kinase 3 betaGSK-3βAdenylate KinaseBiphenyl Compoundsnutraceuticals;PDACβ-cateninGemcitabine?-cateninMalariaPancreatic Neoplasmslcsh:Biology (General)MCF-7DoxorubicinDietary SupplementsCancer researchbiology.protein
researchProduct

Metabolic effect of berberine-silymarin association: A meta-analysis of randomized, double-blind, placebo-controlled clinical trials.

2019

The aim of this study is to assess the impact of a combination of berberine and silymarin on serum lipids and fasting plasma glucose (FPG) through a systematic review of literature and meta-analysis of the available randomized, double-blind, placebo-controlled clinical trials (RCTs). A systematic literature search in SCOPUS, PubMed-Medline, ISI Web of Science, and Google Scholar databases was conducted up to October 2, 2018, in order to identify RCTs assessing changes in plasma concentrations of total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) and FPG during treatment with berberine and silymarin in combina…

Blood Glucosemedicine.medical_specialtysilymarinReviewsBlood lipidsberberine; cholesterol; fasting plasma glucose; meta-analysis; nutraceutical; silymarin; Berberine; Blood Glucose; Double-Blind Method; Fasting; Humans; Lipids; Randomized Controlled Trials as Topic; SilymarinReviewPlaceboGastroenterologymeta-analysiDouble blind03 medical and health scienceschemistry.chemical_compound0302 clinical medicineBerberineDouble-Blind MethodInternal medicineberberineMedicineHumansfasting plasma glucoseRandomized Controlled Trials as TopicPharmacology0303 health sciencesbusiness.industryCholesterolData synthesis030302 biochemistry & molecular biologycholesterolFastingLipidsClinical trialmeta-analysischemistrymeta‐analysis030220 oncology & carcinogenesisMetabolic effectsMeta-analysisnutraceuticalCardiology and Cardiovascular Medicinebusiness
researchProduct

Nutraceuticals and blood pressure control: A European Society of Hypertension position document

2020

: High-normal blood pressure (BP) is associated with an increased risk of cardiovascular disease, however the cost-benefit ratio of the use of antihypertensive treatment in these patients is not yet clear. Some dietary components and natural products seems to be able to significantly lower BP without significant side effects. The aim of this position document is to highlight which of these products have the most clinically significant antihypertensive action and wheter they could be suggested to patients with high-normal BP. Among foods, beetroot juice has the most covincing evidence of antihypertensive effect. Antioxidant-rich beverages (teas, coffee) could be considered. Among nutrients, …

Blood pressure controlPhysiologyPhysiologyDisease030204 cardiovascular system & hematologyResveratrolBeetroot JuiceAntioxidantsMelatoninBeveragesdietary supplements03 medical and health scienceschemistry.chemical_compoundPrehypertensionblood pressure; consensus; dietary supplements; food; nutraceuticals0302 clinical medicineNutraceuticalInternal MedicinemedicineHumansMagnesium030212 general & internal medicineAntihypertensive AgentsMelatoninBlood pressure consensus dietary supplements food nutraceuticalsnutraceuticalsVitamin Cbusiness.industryfoodblood pressureBlood pressurechemistryconsensusHypertensionPotassiumCardiology and Cardiovascular Medicinebusinessmedicine.drug
researchProduct

Nutraceuticals and Cardiovascular Disease

2021

Cardiovascular disease (CVD) remains the primary cause of mortality worldwide, taking an estimated 17.9 million lives each year. Among several cardiometabolic risk factors, dyslipidemia, and especially high low-density lipoprotein cholesterol (LDL-C) levels, are associated with the development and progression of atherosclerosis and its clinical sequelae. Recent studies have shown promising results for nutraceutical compounds on various CVD risk factors and complications. In addition to looking at individual nutrients or foods, dietary pattern have also emerged as a complementary approach to examine the relationship between the overall diet and the risk for CVD. The Mediterranean Diet (MedDi…

Cardiometabolic riskMediterranean dietbusiness.industryCardiovascular healthDiseasemedicine.diseaselaw.inventionNutraceuticalRandomized controlled triallawEnvironmental healthmedicinebusinessDyslipidemiaLipoprotein cholesterol
researchProduct

Innovative Non-Thermal Technologies for Recovery and Valorization of Value-Added Products from Crustacean Processing By-Products—An Opportunity for a…

2021

The crustacean processing industry has experienced significant growth over recent decades resulting in the production of a great number of by-products. Crustacean by-products contain several valuable components such as proteins, lipids, and carotenoids, especially astaxanthin and chitin. When isolated, these valuable compounds are characterized by bioactivities such as anti-microbial, antioxidant, and anti-cancer ones, and that could be used as nutraceutical ingredients or additives in the food, pharmaceutical, and cosmetic industries. Different innovative non-thermal technologies have appeared as promising, safe, and efficient tools to recover these valuable compounds. This review aims at …

CarotenoidNon-thermal technologieHealth (social science)Circular economyChemical technologySeafood industrycarotenoidsnon-thermal technologiesPlant ScienceReviewTP1-1185ReuseHealth Professions (miscellaneous)MicrobiologyastaxanthinNutraceuticalSustainabilityvaluable compoundsBiochemical engineeringBusinessValue addedchitosanFood ScienceFoods
researchProduct

Efficient Production of Isoflavonoids by Astragalus membranaceus Hairy Root Cultures and Evaluation of Antioxidant Activities of Extracts

2014

In this study, Astragalus membranaceus hairy root cultures (AMHRCs) were established as an attractive alternative source for the efficient production of isoflavonoids (IF). A. membranaceus hairy root line II was screened as the most efficient line and was confirmed by PCR amplification of rolB, rolC and aux1 genes. Culture parameters of AMHRCs were systematically optimized, and five main IF constituents were quali-quantitatively determined by LC-MS/MS. Under optimal conditions, the total IF accumulation of 34 day old AMHRCs was 234.77 μg/g dry weight (DW). This yield was significantly higher compared to that of 3 year old field grown roots (187.38 μg/g DW). Additionally, in vitro antioxidan…

ChromatographyAntioxidantbiologymedicine.medical_treatmentCell Culture TechniquesGeneral ChemistryAstragalus propinquusbiology.organism_classificationIsoflavonesPlant RootsAntioxidantsAstragalusNutraceuticalDry weightLc ms msmedicineIc50 valuesFood scienceGeneral Agricultural and Biological SciencesDrugs Chinese HerbalJournal of Agricultural and Food Chemistry
researchProduct

Carnosine Inhibits Aβ42Aggregation by Perturbing the H-Bond Network in and around the Central Hydrophobic Cluster

2013

Aggregation of the amyloid-β peptide (Aβ) into fibrillar structures is a hallmark of Alzheimer's disease. Thus, preventing self-assembly of the Aβ peptide is an attractive therapeutic strategy. Here, we used experimental techniques and atomistic simulations to investigate the influence of carnosine, a dipeptide naturally occurring in the brain, on Aβ aggregation. Scanning force microscopy, circular dichroism and thioflavin T fluorescence experiments showed that carnosine does not modify the conformational features of Aβ42 but nonetheless inhibits amyloid growth. Molecular dynamics (MD) simulations indicated that carnosine interacts transiently with monomeric Aβ42 by salt bridges with charge…

Circular dichroismMagnetic Resonance Spectroscopy1303 BiochemistryStereochemistryStatic ElectricityCarnosinePeptideMolecular Dynamics SimulationBiochemistryproteinprotein interactionsProtein–protein interactionchemistry.chemical_compoundMolecular dynamicsnutraceutical compounds10019 Department of Biochemistry1312 Molecular BiologyMolecular Biologychemistry.chemical_classificationAmyloid beta-PeptidesDipeptideHydrogen bondOrganic ChemistryIntermolecular forceTemperatureneuroprotective agentHydrogen BondingAlzheimer's diseasePeptide Fragmentsmolecular dynamicscarnosinechemistry1313 Molecular Medicine570 Life sciences; biologyMolecular MedicineHydrophobic and Hydrophilic Interactionsprotein aggregation fibrillogenesis carnosine AFM1605 Organic ChemistryChemBioChem
researchProduct

Nutraceuticals Supporting Body Weight Loss

2021

It is known that obesity has reached epidemic proportions and its management is of high clinical importance. In this chapter we will discuss recent data about the role of nutraceuticals and functional foods in obesity and body weight management, including the mechanisms responsible for their favorable effects. In addition, the impact of healthy dietary patterns on weight loss will be addressed. Apart from influencing the imbalance between energy intake and output, nutraceuticals may prevent and/or decrease the development of oxidative stress and inflammation in obesity, as well as favorably influence other cardiovascular disease risk factors, thereby limiting obesity-related complications. …

Clinical PracticeNutraceuticalbusiness.industryWeight lossEnvironmental healthDisease riskMedicineLimitingmedicine.symptombusinessmedicine.diseaseBody weightObesity
researchProduct

Future Perspectives in Nutraceutical Research

2021

Nutraceuticals are largely used by general population. During the last decades, academicians and industries are intensifying the research of new bioactive compounds in order to improve the quality of life and to prevent disease in humans. The quality of the published research is however not always based on the rules of the Good Clinical Practice nor finalized to create a new Evidence-Based nutraceutical sciences. This chapter will resume some basic rules that we will expect to be applied to nutraceutical research in the next years.

Clinical Practiceeducation.field_of_studyNutraceuticalmedia_common.quotation_subjectPopulationEngineering ethicsQuality (business)Businesseducationmedia_common
researchProduct